Recently Featured

The Trade Desk’s Elizabeth Keenan Discusses the Intersection of Music and Pharma Marketing

April 12, 2026
In a recent Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Elizabeth Keenan of The Trade Desk shared insights into her unique journey within the tech-driven landscape of pharma marketing. Keenan elaborated on how her personal experiences have shaped her approach to creating impactful campaigns, emphasizing the importance of authenticity in messaging. She also drew…

Claim of ChatGPT treating Rosie the dog’s cancer stirs AI biotech debate

April 12, 2026
An Australian man has gained attention for his two-year effort to treat his dog, Rosie, an 8-year-old Staffordshire bull terrier mix diagnosed with a common type of skin cancer. The man claims to have utilized ChatGPT, an AI language model, to assist in formulating a treatment plan for Rosie, raising questions about the role of…

OpenEvidence Expands into Prior Authorization and Prescription Routing

April 12, 2026
OpenEvidence, a rapidly emerging health tech startup recognized for its AI-driven medical search engine, is expanding its offerings to include prior authorization and prescription routing services. This strategic move comes as healthcare technology companies increasingly strive to create comprehensive platforms that streamline clinic operations and enhance the efficiency of patient care. The expansion into prior…

ACC 2026: Sotatercept Meta-Analysis Backs Disease-Modifying Role in PAH

April 12, 2026
New data presented at the ACC 2026 conference has clarified the role of sotatercept as a potential disease-modifying therapy in patients with pulmonary arterial hypertension (PAH). This meta-analysis supports the efficacy of sotatercept when used in conjunction with traditional vasodilator-based regimens, highlighting its ability to improve clinical outcomes in this challenging patient population. The findings…

Ongoing Cases